500 New CUSABIO Antibodies at MedStore!

Μέγεθος: px
Εμφάνιση ξεκινά από τη σελίδα:

Download "500 New CUSABIO Antibodies at MedStore!"

Transcript

1 BioMart 500 New CUSABIO Antibodies at MedStore! Purchase two or more units from the attached list of antibodies at MedStore and receive an extra unit for FREE! Valid for purchases made until January 31 st, proof of qualifying purchase to to redeem for free unit. Contact Information: Phone: Fax:

2 ANTIBODY LIST SKU NUMBER ANTIBODY SKU NUMBER ANTIBODY PA012887YA01HU LGALS3 Antibody; 100μg/Unit PA839406LA01HU NR1H4 Antibody; 100μg/Unit PA05689A0Rb CASP3 Antibody; 100μg/Unit PA015248LA01HU MVP Antibody; 100μg/Unit PA00025A0Rb GAPDH Antibody; 100μg/Unit PA00035A0Rb PGK1 Antibody; 100μg/Unit PA06029A0Rb CLU Antibody; 100μg/Unit PA04864A0Rb MRPL9 Antibody; 100μg/Unit PA03724A0Rb PARK7 Antibody; 100μg/Unit PA015624EA01HU NDUFA3 Antibody; 100μg/Unit PA012882HA01HU LGALS1 Antibody; 100μg/Unit PA027127HA01HU ZRANB2 Antibody; 100μg/Unit PA11269A0Rb KRT8 Antibody; 100μg/Unit PA019115HA01HU PYCR1 Antibody; 100μg/Unit PA024013YA01HU TIMP1 Antibody; 100μg/Unit PA009709HA01HU GPD1 Antibody; 100μg/Unit PA05805A0Rb BMP7 Antibody; 100μg/Unit PA613699LA01HU CCBL1 Antibody; 100μg/Unit PA10629A0Rb KRT18 Antibody; 100μg/Unit PA856931LA01HU TRIM11 Antibody; 100μg/Unit PA10887A0Rb HSP90B1 Antibody; 100μg/Unit PA891977EA01HU MINPP1 Antibody; 100μg/Unit PA03425A0Rb BCAP31 Antibody; 100μg/Unit PA623799LA01HU MFAP5 Antibody; 100μg/Unit PA08327A0Rb CXCL8 Antibody; 100μg/Unit PA004407LA01HU CACNA2D1 Antibody; 100μg/Unit PA18109A0Rb CASP8 Antibody; 100μg/Unit PA025785LA01HU VAMP7 Antibody; 100μg/Unit PA07449A0Rb MMP3 Antibody; 100μg/Unit PA07154A0Rb SLPI Antibody; 100μg/Unit PA11869A0Rb MSTN Antibody; 100μg/Unit PA018212EA01HU PLTP Antibody; 100μg/Unit PA010239LA01HU HDAC3 Antibody; 100μg/Unit PA12197A0Rb APOC3 Antibody; 100μg/Unit PA07867A0Rb CALR Antibody; 100μg/Unit PA613490HA01HU ICT1 Antibody; 100μg/Unit PA06615A0Rb IL12B Antibody; 100μg/Unit PA01395A0Rb PSMB1 Antibody; 100μg/Unit PA006008HA01HU CRYAB Antibody; 100μg/Unit PA04145A0Rb SARS Antibody; 100μg/Unit PA06384A0Rb ANXA5 Antibody; 100μg/Unit PA14819A0Rb HLA-DPA1 Antibody; 100μg/Unit PA01544A0Rb YWHAB Antibody; 100μg/Unit PA00704A0Rb B4GALT3 Antibody; 100μg/Unit PA001840HA01HU ANXA2 Antibody; 100μg/Unit PA011022HA01HU IFIT3 Antibody; 100μg/Unit PA001572EA01HU ALDH3A1 Antibody; 100μg/Unit PA015283LA01HU MYEF2 Antibody; 100μg/Unit PA006254YA01HU CXCR4 Antibody; 100μg/Unit PA018603LA01HU PRAME Antibody; 100μg/Unit PA05254A0Rb TRIM28 Antibody; 100μg/Unit PA11275A0Rb SERPINB3 Antibody; 100μg/Unit PA00015A0Rb ALDOA Antibody; 100μg/Unit PA01704A0Rb ENSA Antibody; 100μg/Unit PA01165A0Rb PRDX1 Antibody; 100μg/Unit PA003648LA01HU C1QTNF3 Antibody; 100μg/Unit PA01617A0Rb XRCC6 Antibody; 100μg/Unit PA012927LA01HU LIPA Antibody; 100μg/Unit PA06197A0RB CST3 Antibody; 100μg/Unit PA023908LA01HU TMLHE Antibody; 100μg/Unit PA12807A0Rb HIF1A Antibody; 100μg/Unit PA019135LA01HU QPCT Antibody; 100μg/Unit PA07219A0Rb TFRC Antibody; 100μg/Unit PA871578LA01HU POLR3C Antibody; 100μg/Unit PA005067LA01HU CDK5 Antibody; 100μg/Unit PA001423LA01HU AGA Antibody; 100μg/Unit PA12839A0Rb JUP Antibody; 100μg/Unit PA00595A0Rb RPL8 Antibody; 100μg/Unit PA02905A0Rb RPS6KB2 Antibody; 100μg/Unit PA13289A0Rb MIB1 Antibody; 100μg/Unit PA03934A0Rb DNAJB1 Antibody; 100μg/Unit PA11369A0Rb LCAT Antibody; 100μg/Unit PA07009A0Rb MMP1 Antibody; 100μg/Unit PA012475LA01HU KMO Antibody; 100μg/Unit PA002739LA01HU BMP3 Antibody; 100μg/Unit PA863153LA01HU MRPL20 Antibody; 100μg/Unit PA005947HA01HU CREB1 Antibody; 100μg/Unit PA875664LA01HU CPVL Antibody; 100μg/Unit PA05739A0Rb ANGPT1 Antibody; 100μg/Unit PA313364LA01HU C4B Antibody; 100μg/Unit PA09809A0Rb CKM Antibody; 100μg/Unit PA850802HA01HU CHCHD4 Antibody; 100μg/Unit PA10029A0Rb GDF15 Antibody; 100μg/Unit PA01594A0Rb NDUFB7 Antibody; 100μg/Unit PA12849A0Rb FGF2 Antibody; 100μg/Unit PA025681HA01HU USF1 Antibody; 100μg/Unit PA00575A0Rb PSMD11 Antibody; 100μg/Unit PA016318HA01HU OLA1 Antibody; 100μg/Unit PA023510LA01HU THRA Antibody; 100μg/Unit PA620986HA01HU UGP2 Antibody; 100μg/Unit PA006621LA01HU DDX3X Antibody; 100μg/Unit PA05195A0Rb SCAMP3 Antibody; 100μg/Unit PA022398LA01HU SOD2 Antibody; 100μg/Unit PA12319A0Rb PRSS3 Antibody; 100μg/Unit PA889102LA01HU RAD18 Antibody; 100μg/Unit PA021643LA01HU SLC41A2 Antibody; 100μg/Unit PA883363LA01HU ASH2L Antibody; 100μg/Unit PA850268HA01HU GALM Antibody; 100μg/Unit PA01555A0Rb RPA2 Antibody; 100μg/Unit PA01284A0Rb DYNLL1 Antibody; 100μg/Unit PA03065A0Rb GOT2 Antibody; 100μg/Unit PA02635A0Rb SNRPD2 Antibody; 100μg/Unit PA11759A0Rb BSG Antibody; 100μg/Unit PA03455A0Rb ZNF384 Antibody; 100μg/Unit PA009143LA01HU GABRA4 Antibody; 100μg/Unit PA006867DA01HU DHRS9 Antibody; 100μg/Unit PA004601HA01HU CBX5 Antibody; 100μg/Unit PA00454A0Rb HSBP1 Antibody; 100μg/Unit

3 PA017489HA01HU PAX3 Antibody; 100μg/Unit PA889116HA01HU DDX19A Antibody; 100μg/Unit PA019260LA01HU RAD23B Antibody; 100μg/Unit PA01814A0Rb C21orf33 Antibody; 100μg/Unit PA006425EA01HU CYP2E1 Antibody; 100μg/Unit PA02604A0Rb AP2S1 Antibody; 100μg/Unit PA07057A0Rb RBP4 Antibody; 100μg/Unit PA17354A0Rb MT2A Antibody; 100μg/Unit PA03774A0Rb RAD23A Antibody; 100μg/Unit PA02989A0Rb NDUFA2 Antibody; 100μg/Unit PA07019A0Rb MMP10 Antibody; 100μg/Unit PA05095A0Rb BTBD2 Antibody; 100μg/Unit PA07764A0Rb FABP3 Antibody; 100μg/Unit PA019794LA01HU RNASE2 Antibody; 100μg/Unit PA02775A0Rb NME1 Antibody; 100μg/Unit PA881001LA01HU WDR54 Antibody; 100μg/Unit PA03334A0Rb SYNCRIP Antibody; 100μg/Unit PA021820DA01HU SMCP Antibody; 100μg/Unit PA020632HA01HU S100A4 Antibody; 100μg/Unit PA04965A0Rb COMMD4 Antibody; 100μg/Unit PA009965HA01HU GSN Antibody; 100μg/Unit PA17364A0Rb MT1E Antibody; 100μg/Unit PA07589AORB INHBA Antibody; 100μg/Unit PA02005A0Rb ZNF91 Antibody; 100μg/Unit PA07545A0Rb VEGFC Antibody; 100μg/Unit PA862039EA01HU GEMIN7 Antibody; 100μg/Unit PA00915A0Rb ARF4 Antibody; 100μg/Unit PA01804A0Rb RPL36AL Antibody; 100μg/Unit PA02655A0Rb CYB5R3 Antibody; 100μg/Unit MA065241A0m IFNG Antibody; 100μg/Unit PA11729A0Rb FOLH1 Antibody; 100μg/Unit MA A0m Growthhormone(GH)Antibody; 100μg/unit PA00804A0Rb TAGLN Antibody; 100μg/Unit MA A0m S100A9 Antibody; 100μg/Unit PA018369EA01HU PON1 Antibody; 100μg/Unit MA A0m S100B Antibody; 100μg/Unit PA02495A0Rb RPL5 Antibody; 100μg/Unit MA058641A0m CCL2 Antibody; 100μg/Unit PA010763LA01HU HSD11B1 Antibody; 100μg/Unit MA167191A0m Timp1 Antibody; 100μg/Unit PA001715LA01HU ANGPTL7 Antibody; 100μg/Unit MA069022A0m SPP1 Antibody; 100μg/Unit PA10047A0Rb TNNT2 Antibody; 100μg/Unit MA112991A0m PGC Antibody; 100μg/Unit PA009514LA01HU GLP1R Antibody; 100μg/Unit MA005111I0m FITC Antibody; 100μg/Unit PA02174A0Rb YWHAH Antibody; 100μg/Unit MA000011M0m 6 His Antibody; 100μg/Unit PA13749A0Rb TROVE2 Antibody; 100μg/Unit MA000021M0m Flag Tag Antibody; 100μg/Unit PA007593LA01HU ELAVL2 Antibody; 100μg/Unit MA000071M0m GAPDH Antibody; 100μg/Unit PA02325A0Rb FKBP1A Antibody; 100μg/Unit MA000051M0m GFP Antibody; 100μg/Unit PA02704A0Rb FUS Antibody; 100μg/Unit MA000031M0m GST Antibody; 100μg/Unit PA14209A0Rb AGER Antibody; 100μg/Unit MA000061M0m MBP Antibody; 100μg/Unit PA01345A0Rb PSMB7 Antibody; 100μg/Unit MA000041M0m MYC Antibody; 100μg/Unit PA020225DA01HU RPL30 Antibody; 100μg/Unit MA000132M0m SUMO Antibody; 100μg/Unit PA03865A0Rb KAT7 Antibody; 100μg/Unit MA A0m CD59 Antibody; 100μg/Unit PA12639A0Rb Amh Antibody; 100μg/Unit MA A0m CD14 Antibody; 100μg/Unit PA600104LA01HU EHHADH Antibody; 100μg/Unit MA A0m CHGA Antibody; 100μg/Unit PA14647A0Rb Kng1 Antibody; 100μg/Unit MA A0m ANXA2 Antibody; 100μg/Unit PA01515A0Rb CYC1 Antibody; 100μg/Unit MA A0m IL1F10 Antibody; 100μg/Unit PA02395A0Rb ENO1 Antibody; 100μg/Unit MA A0m TGM2 Antibody; 100μg/Unit PA00474A0Rb UBE2I Antibody; 100μg/Unit MA A0m BCL2L1 Antibody; 100μg/Unit PA009679HA01HU GOT1 Antibody; 100μg/Unit MA A0m CD81 Antibody; 100μg/Unit PA019122EA01HU PYGL Antibody; 100μg/Unit MA A0m MSH6 Antibody; 100μg/Unit PA06404A0Rb FGF21 Antibody; 100μg/Unit MA A0m MYCBP Antibody; 100μg/Unit PA007563YA01HU EIF4EBP2 Antibody; 100μg/Unit MA A0m TP53 Antibody; 100μg/Unit PA002601LA01HU BCAT2 Antibody; 100μg/Unit PA703610DSR2HU PDCD4 Antibody; 100μl/Unit PA019092HA01HU PVALB Antibody; 100μg/Unit PA002608ESR2HU BCL10 Antibody; 100μl/Unit PA865121LA01HU AASDHPPT Antibody; 100μg/Unit PA009276ESR2HU GATA3 Antibody; 100μl/Unit PA022831HA01HU STIP1 Antibody; 100μg/Unit PA018846ESR2HU PSEN1 Antibody; 100μl/Unit PA00414A0Rb COX5A Antibody; 100μg/Unit PA006737DSR2HU DFFA Antibody; 100μl/Unit PA00535A0Rb ODC1 Antibody; 100μg/Unit PA021073ESR2HU SERPINB5 Antibody; 100μl/Unit PA03255A0Rb PHGDH Antibody; 100μg/Unit PA002005ESR2HU ARG1 Antibody; 100μl/Unit PA023577HA01HU TK1 Antibody; 100μg/Unit PA014786ESR1HU MRE11A Antibody; 100μl/Unit PA00114A0Rb ILF2 Antibody; 100μg/Unit PA858702ESR1HU GAD1 Antibody; 100μl/Unit PA00985A0Rb PPP2CB Antibody; 100μg/Unit PA013412ESR2HU MAP2K3 Antibody; 100μl/Unit PA017456LA01HU PARN Antibody; 100μg/Unit PA619756ESR2HU MAD2L1 Antibody; 100μl/Unit PA00675A0Rb MP68 Antibody; 100μg/Unit PA734569ESR1HU ATG16L1 Antibody; 100μl/Unit PA007734LA01HU EPHX1 Antibody; 100μg/Unit PA010902ESR2HU HTRA2 Antibody; 100μl/Unit PA008699HA01HU FKBP3 Antibody; 100μg/Unit PA002384ESR2HU ATP6AP2 Antibody; 100μl/Unit PA00585A0Rb TPMT Antibody; 100μg/Unit PA010989ESR1HU IDH1 Antibody; 100μl/Unit PA01874A0Rb RPS11 Antibody; 100μg/Unit PA618753ESR2HU CDC16 Antibody; 100μl/Unit PA01385A0Rb PSMB2 Antibody; 100μg/Unit PA020059ESR1HU ROCK2 Antibody; 100μl/Unit

4 PA01435A0Rb H3F3A Antibody; 100μg/Unit PA022813ESR2HU STAT4 Antibody; 100μl/Unit PA02485A0Rb RPS13 Antibody; 100μg/Unit PA622641DSR1HU PAK2 Antibody; 100μl/Unit PA03124A0Rb DAD1 Antibody; 100μg/Unit PA004551ESR2HU CASP6 Antibody; 100μl/Unit PA00655A0Rb RPS19BP1 Antibody; 100μg/Unit PA026290ESR1HU YWHAQ Antibody; 100μl/Unit PA613499HA01HU GALE Antibody; 100μg/Unit PA621652ESR1HU TARDBP Antibody; 100μl/Unit PA021065LA01HU SERPINB1 Antibody; 100μg/Unit PA897574ESR1HU LYVE1 Antibody; 100μl/Unit PA009466LA01HU GK2 Antibody; 100μg/Unit PA621968ESR2HU MLANA Antibody; 100μl/Unit PA863128LA01HU DUSP26 Antibody; 100μg/Unit PA015422ESR2HU NAMPT Antibody; 100μl/Unit PA01495A0Rb CKB Antibody; 100μg/Unit PA019307ESR1HU RAN Antibody; 100μl/Unit PA08179A0Rb RELT Antibody; 100μg/Unit PA887006ESR1HU TNFRSF10D Antibody; 100μl/Unit PA06275A0Rb POR Antibody; 100μg/Unit PA012394DSR2HU KLF4 Antibody; 100μl/Unit PA002226HA01HU ASPH Antibody; 100μg/Unit PA836199ESR2HU ATG4C Antibody; 100μl/Unit PA897480LA01HU DHRS7 Antibody; 100μg/Unit PA002714ESR2HU BLK Antibody; 100μl/Unit PA04645A0Rb UQCRFS1 Antibody; 100μg/Unit PA004364ESR1HU Ca1 Antibody; 100μl/Unit PA010565LA01HU HMGCR Antibody; 100μg/Unit PA026233DSR2HU XRCC5 Antibody; 100μl/Unit PA04005A0Rb AFG3L2 Antibody; 100μg/Unit PA624033ESR2HU TAB1 Antibody; 100μl/Unit PA12109A0Rb ICA1 Antibody; 100μg/Unit PA852885ESR1HU HSPH1 Antibody; 100μl/Unit PA00465A0Rb YARS Antibody; 100μg/Unit PA001260ESR2HU ACVR2A Antibody; 100μl/Unit PA03465A0Rb RRAGA Antibody; 100μg/Unit PA621519ESR2HU MERTK Antibody; 100μl/Unit PA017942DA01HU PHPT1 Antibody; 100μg/Unit PA883368ESR2HU MORF4L1 Antibody; 100μl/Unit PA896688LA01HU ERGIC3 Antibody; 100μg/Unit PA882102ESR2HU SIRT3 Antibody; 100μl/Unit PA007432LA01HU EEF1E1 Antibody; 100μg/Unit PA001257ESR2HU ACVR1 Antibody; 100μl/Unit PA872519HA01HU MOB1A Antibody; 100μg/Unit PA854112ESR1HU ACVR1C Antibody; 100μl/Unit PA025443DA01HU UBE2D1 Antibody; 100μg/Unit PA006497ESR2HU DAP3 Antibody; 100μl/Unit PA839418LA01HU NMNAT3 Antibody; 100μg/Unit PA016076ESR1HU NRF1 Antibody; 100μl/Unit PA848395LA01HU PIGX Antibody; 100μg/Unit PA010244ESR2HU HDAC8 Antibody; 100μl/Unit PA03075A0Rb EXTL3 Antibody; 100μg/Unit PA019213ESR1HU RAB5A Antibody; 100μl/Unit PA006031LA01HU CS Antibody; 100μg/Unit PA023570ESR1HU TIRAP Antibody; 100μl/Unit PA01335A0Rb PSMA7 Antibody; 100μg/Unit PA866314ESR2HU ANGPTL4 Antibody; 100μl/Unit PA02109A0RB HLA-G Antibody; 100μg/Unit PA843284ESR1HU ARFGAP1 Antibody; 100μl/Unit PA05345A0Rb ERP29 Antibody; 100μg/Unit PA017492DSR2HU PAX6 Antibody; 100μl/Unit PA011723LA01HU INMT Antibody; 100μg/Unit PA017731ESR2HU PDLIM1 Antibody; 100μl/Unit PA618010LA01HU TEAD4 Antibody; 100μg/Unit PA878084ESR1HU SH3GLB1 Antibody; 100μl/Unit PA801242LA01HU MON1A Antibody; 100μg/Unit PA015044ESR1HU MSLN Antibody; 100μl/Unit PA12529A0Rb FUCA2 Antibody; 100μg/Unit PA001632ESR1HU ALPP Antibody; 100μl/Unit PA14809A0Rb HLA-DPB1 Antibody; 100μg/Unit PA004775ESR2HU CCL11 Antibody; 100μl/Unit PA010138HA01HU HARS2 Antibody; 100μg/Unit PA004925ESR1HU CD33 Antibody; 100μl/Unit PA022722HA01HU SSSCA1 Antibody; 100μg/Unit PA005574ESR1HU CLOCK Antibody; 100μl/Unit PA874841HA01HU MRPL1 Antibody; 100μg/Unit PA001940ESR2HU APOL1 Antibody; 100μl/Unit PA009417YA01HU GIF Antibody; 100μg/Unit PA867133ESR1HU CARD9 Antibody; 100μl/Unit PA836212LA01HU GALNT14 Antibody; 100μg/Unit PA804958ESR1HU MEF2C Antibody; 100μl/Unit PA02315A0Rb COX6A1 Antibody; 100μg/Unit PA818781DSR1HU GPRC5A Antibody; 100μl/Unit PA13109A0Rb CDH12 Antibody; 100μg/Unit PA614396ESR2HU STK3 Antibody; 100μl/Unit PA00845A0Rb CDA Antibody; 100μg/Unit PA009927ESR2HU GRK6 Antibody; 100μl/Unit PA009055LA01HU FTSJ1 Antibody; 100μg/Unit PA001996ESR1HU ARF6 Antibody; 100μl/Unit PA014826EA01HU MRPL19 Antibody; 100μg/Unit PA623654ESR2HU SMARCB1 Antibody; 100μl/Unit PA02345A0Rb RPL27 Antibody; 100μg/Unit PA004490ESR2HU CAPN1 Antibody; 100μl/Unit PA022366EA01HU SNX20 Antibody; 100μg/Unit PA340572ESR1HU GATA2 Antibody; 100μl/Unit PA01989A0Rb SDHA Antibody; 100μg/Unit PA615667ESR2HU MAP2K5 Antibody; 100μl/Unit PA836666HA01HU HDDC3 Antibody; 100μg/Unit PA619774ESR1HU ASAH1 Antibody; 100μl/Unit PA731035LA01HU METRNL Antibody; 100μg/Unit PA621879ESR2HU TRADD Antibody; 100μl/Unit PA14389A0Rb SEPSECS Antibody; 100μg/Unit PA868396ESR2HU EIF2AK4 Antibody; 100μl/Unit PA00304A0Rb DDX39B Antibody; 100μg/Unit PA621688ESR2HU IL10RA Antibody; 100μl/Unit PA11069A0Rb AVP Antibody; 100μg/Unit PA017467ESR1HU PARP3 Antibody; 100μl/Unit PA892161LA01HU DIMT1 Antibody; 100μg/Unit PA023438DSR2HU TFPI2 Antibody; 100μl/Unit PA00135A0Rb ATP6V1G1 Antibody; 100μg/Unit PA025944ESR1HU VTN Antibody; 100μl/Unit PA636327LA01HU IZUMO4 Antibody; 100μg/Unit PA022815ESR1HU STAT5B Antibody; 100μl/Unit PA896556LA01HU COLEC10 Antibody; 100μg/Unit PA011621ESR1HU IL1R1 Antibody; 100μl/Unit PA011040LA01HU IFNA4 Antibody; 100μg/Unit PA001545ESR2HU AKR1C4 Antibody; 100μl/Unit

5 PA010094DA01HU H2AFJ Antibody; 100μg/Unit PA001845ESR2HU ANXA4 Antibody; 100μl/Unit PA011035EA01HU IFNA14 Antibody; 100μg/Unit PA002279ESR1HU ATF7 Antibody; 100μl/Unit PA008005LA01HU FAM110B Antibody; 100μg/Unit PA619868ESR1HU FLOT2 Antibody; 100μl/Unit PA011033LA01HU IFNA10 Antibody; 100μg/Unit PA013595ESR1HU MCM5 Antibody; 100μl/Unit PA002333LA01HU ATP2A2 Antibody; 100μg/Unit PA001134ESR1HU ACAT1 Antibody; 100μl/Unit PA11319A0Rb MUC1 Antibody; 100μg/Unit PA001568ESR1HU ALDH1B1 Antibody; 100μl/Unit PA010082LA01HU GZMB Antibody; 100μg/Unit PA002526ESR1HU BACH1 Antibody; 100μl/Unit PA05437A0Rb PAK4 Antibody; 100μg/Unit PA004814ESR2HU CCND3 Antibody; 100μl/Unit PA07475A0Rb TNFSF10 Antibody; 100μg/Unit PA023979DSR2HU TNFRSF21 Antibody; 100μl/Unit PA15229A0Rb FOXP3 Antibody; 100μg/Unit PA004587ESR1HU CBR3 Antibody; 100μl/Unit PA10657A0Rb MUC16 Antibody; 100μg/Unit PA002761ESR1HU BMX Antibody; 100μl/Unit PA06974A0Rb CTSB Antibody; 100μg/Unit PA008619ESR1HU FGF13 Antibody; 100μl/Unit PA09929A0Rb NTF4 Antibody; 100μg/Unit PA010143ESR2HU HAT1 Antibody; 100μl/Unit PA05864A0Rb CCL2 Antibody; 100μg/Unit PA023062ESR1HU TAC1 Antibody; 100μl/Unit PA16539A0Rb SOX2 Antibody; 100μg/Unit PA001544ESR1HU AKR1C3 Antibody; 100μl/Unit PA00794A0Rb ANXA6 Antibody; 100μg/Unit PA007466ESR2HU EFNB2 Antibody; 100μl/Unit PA06369A0Rb AHSG Antibody; 100μg/Unit PA005273ESR2HU CFH Antibody; 100μl/Unit PA11999A0Rb Alpl Antibody; 100μg/Unit PA887041ESR1HU DPP7 Antibody; 100μl/Unit PA05104A0Rb ANAPC5 Antibody; 100μg/Unit PA013591ESR1HU MCM3 Antibody; 100μl/Unit PA14609A0Rb HP Antibody; 100μg/Unit PA614418ESR1HU MTM1 Antibody; 100μl/Unit PA00667A0Rb AIF1 Antibody; 100μg/Unit PA017493ESR1HU PAX7 Antibody; 100μl/Unit PA012512LA01HU KRT14 Antibody; 100μg/Unit PA859113ESR2HU PRMT1 Antibody; 100μl/Unit PA06834A0Rb LCN2 Antibody; 100μg/Unit PA837133ESR1HU PTRH2 Antibody; 100μl/Unit PA004947EA01HU CD59 Antibody; 100μg/Unit PA012138ESR1HU KDM4B Antibody; 100μl/Unit PA025394LA01HU TYR Antibody; 100μg/Unit PA009319ESR1HU GCK Antibody; 100μl/Unit PA00875A0Rb RHOA Antibody; 100μg/Unit PA001566ESR1HU ALDH1A2 Antibody; 100μl/Unit PA006392EA01HU CYP17A1 Antibody; 100μg/Unit PA864024ESR1HU ARNT2 Antibody; 100μl/Unit PA05264A0Rb AATF Antibody; 100μg/Unit PA006630ESR2HU DDX5 Antibody; 100μl/Unit PA08467A0Rb TNFRSF11A Antibody; 100μg/Unit PA013621ESR1HU MDH1 Antibody; 100μl/Unit PA11749A0Rb TIMP3 Antibody; 100μg/Unit PA022389ESR2HU SOCS2 Antibody; 100μl/Unit PA020071LA01HU RORC Antibody; 100μg/Unit PA023386ESR2HU TERF1 Antibody; 100μl/Unit PA09674A0Rb TACR1 Antibody; 100μg/Unit PA001540ESR2HU AKR1B10 Antibody; 100μl/Unit PA06139A0Rb CXCL13 Antibody; 100μg/Unit PA001848ESR1HU ANXA7 Antibody; 100μl/Unit PA11049A0Rb CFB Antibody; 100μg/Unit PA005036ESR1HU CDH11 Antibody; 100μl/Unit PA006389LA01HU CYP11A1 Antibody; 100μg/Unit PA005462ESR2HU CKMT2 Antibody; 100μl/Unit PA860776HA01HU HSD17B10 Antibody; 100μg/Unit PA822187ESR1HU DHX58 Antibody; 100μl/Unit PA020642HA01HU S100A9 Antibody; 100μg/Unit PA822241DSR1HU PBK Antibody; 100μl/Unit PA012930YA01HU LIG1 Antibody; 100μg/Unit PA618976ESR2HU PDK2 Antibody; 100μl/Unit PA11464A0Rb COL4A1 Antibody; 100μg/Unit PA001519ESR1HU AKAP10 Antibody; 100μl/Unit PA001370HA01HU ADM Antibody; 100μg/Unit PA005545ESR1HU CLIC1 Antibody; 100μl/Unit PA622767LA01HU GCKR Antibody; 100μg/Unit PA883367ESR2HU DKK4 Antibody; 100μl/Unit PA10729A0Rb Ctss Antibody; 100μg/Unit PA008700ESR1HU FKBP4 Antibody; 100μl/Unit PA01405A0Rb MYH9 Antibody; 100μg/Unit PA745339ESR1HU RRM2B Antibody; 100μl/Unit PA15549A0Rb WNT3A Antibody; 100μg/Unit PA002350ESR2HU ATP5B Antibody; 100μl/Unit PA08047A0Rb TNFSF9 Antibody; 100μg/Unit PA890743ESR1HU BAG5 Antibody; 100μl/Unit PA06039A0Rb CNTF Antibody; 100μg/Unit PA008793ESR2HU FOSL2 Antibody; 100μl/Unit PA10709A0Rb BMP6 Antibody; 100μg/Unit PA822717ESR2HU IL22RA1 Antibody; 100μl/Unit PA005743LA01HU COL4A3 Antibody; 100μg/Unit PA017490ESR1HU PAX4 Antibody; 100μl/Unit PA02814A0Rb TXN Antibody; 100μg/Unit PA015530DSR2HU NCK1 Antibody; 100μl/Unit PA05385A0Rb NDUFV2 Antibody; 100μg/Unit PA011670ESR1HU IL7R Antibody; 100μl/Unit PA11989A0Rb ALPI Antibody; 100μg/Unit PA004946ESR1HU CD58 Antibody; 100μl/Unit PA012483LA01HU KPNA1 Antibody; 100μg/Unit PA009458ESR2HU GJC1 Antibody; 100μl/Unit PA010967LA01HU ID2 Antibody; 100μg/Unit PA001248ESR1HU ACTR2 Antibody; 100μl/Unit PA13019A0Rb NR1I3 Antibody; 100μg/Unit PA618777ESR2HU BIRC2 Antibody; 100μl/Unit PA001362LA01HU ADH7 Antibody; 100μg/Unit PA618874DSR1HU HNRNPD Antibody; 100μl/Unit PA00367A0Rb Gpi Antibody; 100μg/Unit PA618894ESR2HU MCM6 Antibody; 100μl/Unit PA07419A0Rb TIMP4 Antibody; 100μg/Unit PA620952DSR1HU SEPT7 Antibody; 100μl/Unit PA012022LA01HU KCND1 Antibody; 100μg/Unit PA840976ESR1HU NPRL2 Antibody; 100μl/Unit PA016331LA01HU OLR1 Antibody; 100μg/Unit PA852913DSR2HU EZH1 Antibody; 100μl/Unit

6 PA13354A0Rb STEAP1 Antibody; 100μg/Unit PA001246ESR1HU ACTR1A Antibody; 100μl/Unit PA12224A0Rb IAPP Antibody; 100μg/Unit PA005789ESR1HU COPS2 Antibody; 100μl/Unit PA14129A0Rb GRIN2A Antibody; 100μg/Unit PA613389ESR1HU G3BP1 Antibody; 100μl/Unit PA860344LA01HU TEAD3 Antibody; 100μg/Unit PA010647DSR1HU HOXA1 Antibody; 100μl/Unit PA03604A0Rb TRAP1 Antibody; 100μg/Unit PA010774ESR1HU HSD17B4 Antibody; 100μl/Unit PA04154A0Rb PFN1 Antibody; 100μg/Unit PA836180ESR1HU PNPLA2 Antibody; 100μl/Unit PA016221LA01HU NXF3 Antibody; 100μg/Unit PA018474ESR1HU PPID Antibody; 100μl/Unit PA02925A0Rb PRKCSH Antibody; 100μg/Unit PA019093ESR1HU PVR Antibody; 100μl/Unit PA09817A0Rb CKMT1A Antibody; 100μg/Unit PA891560ESR2HU SUFU Antibody; 100μl/Unit PA13447A0Rb PODXL Antibody; 100μg/Unit PA024464ESR2HU TRIM27 Antibody; 100μl/Unit PA16739A0Rb Il18bp Antibody; 100μg/Unit PA857458ESR2HU TXN2 Antibody; 100μl/Unit PA09905A0Rb POSTN Antibody; 100μg/Unit PA860799ESR1HU ACY1 Antibody; 100μl/Unit PA762574HA01HU MOB1B Antibody; 100μg/Unit PA007286ESR1HU DVL2 Antibody; 100μl/Unit PA019523LA01HU RDH11 Antibody; 100μg/Unit PA010137ESR2HU HARS Antibody; 100μl/Unit PA019153HA01HU RAB11A Antibody; 100μg/Unit PA839866DSR1HU MCPH1 Antibody; 100μl/Unit PA016315LA01HU OGT Antibody; 100μg/Unit PA614899ESR2HU NAB2 Antibody; 100μl/Unit PA839329HA01HU DCUN1D1 Antibody; 100μg/Unit PA761274ESR1HU SLC27A4 Antibody; 100μl/Unit PA05909A0Rb CCL24 Antibody; 100μg/Unit PA023429ESR1HU TFEB Antibody; 100μl/Unit PA05154A0Rb MYL6 Antibody; 100μg/Unit PA887999ESR1HU ACAD9 Antibody; 100μl/Unit

Product Name Code Size Application

Product Name Code Size Application 6 His monoclonal antibody CSB-MA000011M0m 100μg ELISA, WB AADAT Antibody CSB-PA843276LA01HU 100μg ELISA, IHC AARSD1 Antibody CSB-PA863119LA01HU 100μg ELISA, WB, IHC AASDHPPT Antibody CSB-PA865121LA01HU

Διαβάστε περισσότερα

Lee et al., Suppl. Fig. 1

Lee et al., Suppl. Fig. 1 Lee et al., Suppl. Fig. 1 Lee et al., Suppl. Fig. 2 Lee et al., Suppl. Fig. 3 Lee et al., Suppl. Fig. 4 Lee et al., Suppl. Fig. 5 Lee et al., Supplementary Table 1 Markers Percentage of p75+ cells [Mean

Διαβάστε περισσότερα

TFDP2 TFDP1 SUMO1 SERTAD1 RPA3 RBBP8 RAD9A RAD17 RAD1 NBN MRE11A MNAT1 KPNA2 KNTC1 HUS1 HERC5 GTSE1 GTF2H1 GADD45A E2F4 DNM2 DDX11 CUL3 SKP2 RBL1 RB1

TFDP2 TFDP1 SUMO1 SERTAD1 RPA3 RBBP8 RAD9A RAD17 RAD1 NBN MRE11A MNAT1 KPNA2 KNTC1 HUS1 HERC5 GTSE1 GTF2H1 GADD45A E2F4 DNM2 DDX11 CUL3 SKP2 RBL1 RB1 -8-6 -4-2 CHEK2 MKI67 RB1 RBL1 SKP2 Fold-Change Fold-Change -3-2 -1 CCND1 CCNE1 CDK4 CDK5R1 5 1 15 ATM ATR BAX BCCIP BRCA1 BRCA2 BL1AT ABL1A ABL1 CCNG1 CCNG2 CCNH CCNT1 CCNT2 CDC2 CDC34 CDKN1A CDKN1B CDKN2A

Διαβάστε περισσότερα

Supplementary Figure 1. Therapeutic efficacy of combined NDV and anti-ctla-4 therapy is attenuated with a larger tumor challenge.

Supplementary Figure 1. Therapeutic efficacy of combined NDV and anti-ctla-4 therapy is attenuated with a larger tumor challenge. Supplementary Figure 1. Therapeutic efficacy of combined NDV and anti-ctla-4 therapy is attenuated with a larger tumor challenge. Bilateral flank B16-F10 tumors were established as described and the animals

Διαβάστε περισσότερα

Biological marks of early-life socioeconomic experience is detected in the adult inflammatory transcriptome

Biological marks of early-life socioeconomic experience is detected in the adult inflammatory transcriptome Biological marks of early-life socioeconomic experience is detected in the adult inflammatory transcriptome Raphaële Castagné 1,2,3, Michelle Kelly-Irving 2,3, Gianluca Campanella 1, Florence Guida 1,

Διαβάστε περισσότερα

SUPPLEMENTARY INFORMATION

SUPPLEMENTARY INFORMATION doi:10.1038/nature22977 Supplementary Data 1 Fig. 4d + CM (no MDK) + CM (MDK) 10 15 30 1h 12h 24h 10 15 30 1h 12h 24h P- P- Fig. 4e CM GoF CM LoF-M5 CM GoF MDK - + + - + + + Vehicle - + + - + + + Rapamycin

Διαβάστε περισσότερα

Prostate-targeted radiosensitization via aptamer-shrna chimeras in human. tumor xenografts

Prostate-targeted radiosensitization via aptamer-shrna chimeras in human. tumor xenografts SUPPLEMENTARY DATA Prostate-targeted radiosensitization via aptamer-shrna chimeras in human tumor xenografts Xiaohua Ni 1, Yonggang Zhang 2, Judit Ribas 1, Wasim H. Chowdhury 1, Mark Castanares 1, Zhewei

Διαβάστε περισσότερα

The following primers were used for RT-PCR: GAPDH forward (Fw) 5 -GAA GGT GAA GGT

The following primers were used for RT-PCR: GAPDH forward (Fw) 5 -GAA GGT GAA GGT Supplementary Material and Methods RT-PCR Primers The following primers were used for RT-PCR: GAPDH forward (Fw) 5 -GAA GGT GAA GGT CGG AGT C-3, GAPDH reverse (Rev) 5 -GAA GAT GGT GAT GGG ATT TC-3, GPX3

Διαβάστε περισσότερα

GeneCopoeia provides five qpcr array formats (A, B, C, D, and E) suitable for use with the following realtime

GeneCopoeia provides five qpcr array formats (A, B, C, D, and E) suitable for use with the following realtime GeneCopoeia TM Expressway to Discovery ExProfile TM Human Lung Cancer Gene qpcr Array For focused group profiling of human lung cancer related genes expression Cat. No. QG071-A (6 x 96-well plate, Format

Διαβάστε περισσότερα

GeneTex Sonderaktion: Custom Antibody Panels

GeneTex Sonderaktion: Custom Antibody Panels (Stand 01/2016) GeneTex Sonderaktion: Custom Antibody Panels Fünf Antikörper (in der 25 µl-größe) zum Sonderpreis von nur 420,00 (statt 545,00 ). Bitte geben Sie bei Ihrer Bestellung die Angebotsnummer

Διαβάστε περισσότερα

Supplementary Table 1. Composition of the diets

Supplementary Table 1. Composition of the diets Supplementary Table 1. Composition of the diets Standard diet High Fat diet Energy content (kcal/kg) 2508 3701 Protein (g/kg) 200 170 Carbohydrate (g/kg) 720 670 Total fat (g/kg) 80 160 Saturated fatty

Διαβάστε περισσότερα

Correlation of nonsilent somatic mutations with the age and the disease stage of 25 people with NKTCL, subjected to whole-exome sequencing.

Correlation of nonsilent somatic mutations with the age and the disease stage of 25 people with NKTCL, subjected to whole-exome sequencing. Supplementary Figure 1 Correlation of nonsilent somatic mutations with the age and the disease stage of 25 people with NKTCL, subjected to whole-exome sequencing. (a) Distribution of non-silent somatic

Διαβάστε περισσότερα

GeneCopoeia provides five qpcr array formats (A, B, C, D, and E) suitable for use with the following realtime

GeneCopoeia provides five qpcr array formats (A, B, C, D, and E) suitable for use with the following realtime GeneCopoeia TM Expressway to Discovery ExProfile TM Human Breast Cancer Gene qpcr Array For focused group profiling of human breast cancer related genes expression Cat. No. QG063-A (6 x 96-well plate,

Διαβάστε περισσότερα

Supplementary Material: Phenotype-Genotype Association Analysis of ACTH-Secreting Pituitary Adenoma and Its Molecular Link to Patient Osteoporosis

Supplementary Material: Phenotype-Genotype Association Analysis of ACTH-Secreting Pituitary Adenoma and Its Molecular Link to Patient Osteoporosis S1 of S29 Supplementary Material: Phenotype-Genotype Association Analysis of ACTH-Secreting Pituitary Adenoma and Its Molecular Link to Patient Osteoporosis Renzhi Wang, Yakun Yang, Miaomiao Sheng, Dechao

Διαβάστε περισσότερα

Nature Medicine doi: /nm.2772

Nature Medicine doi: /nm.2772 Supplementary Table 1: FOXO3a and/or beta catenin regulated genes (12 h treatment) FC 4OHT FC DOX FC 4OHT+DOX FC 4OHT+DOX Known Gene Symbol vs. Vehicle P value* vs. Vehicle P value* vs. Vehicle P value*

Διαβάστε περισσότερα

SABiosciences PCR Array Catalog #: PAHS-021 SA+ SCF 4h stimulaton AVG(Ct) Position Unigene Refseq Symbol Description shcontr shcontr-4h shgskβ A01

SABiosciences PCR Array Catalog #: PAHS-021 SA+ SCF 4h stimulaton AVG(Ct) Position Unigene Refseq Symbol Description shcontr shcontr-4h shgskβ A01 SABiosciences PCR Array Catalog #: PAHS-021 SA+ SCF 4h stimulaton AVG(Ct) Position Unigene Refseq Symbol Description shcontr shcontr-4h shgskβ A01 Hs.1274 NM_006129 BMP1 Bone morphogenetic protein 1 25.25

Διαβάστε περισσότερα

SUPPLEMENTARY INFORMATION MicroRNA-195 attenuates Epithelial-Mesenchymal-Transition (EMT) in breast cancer cells by targeting FASN, HMGCR, ACACA and CYP27B1 Richa Singh, Vikas Yadav, Sachin Kumar and Neeru

Διαβάστε περισσότερα

Increasing the level of Peroxisome Proliferator-Activated Receptor Gamma. Supplement Figure 1. Regulation of PGC1α expression in cultured podocytes.

Increasing the level of Peroxisome Proliferator-Activated Receptor Gamma. Supplement Figure 1. Regulation of PGC1α expression in cultured podocytes. Increasing the level of Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1 α in podocytes results in collapsing glomerulopathy Supplement Figure 1. Regulation of PGC1α expression in cultured

Διαβάστε περισσότερα

NCBI ID Symbol 2 A2M A4GALT A4GNT 8086 AAAS 13 AADAC AADACL AAGAB 15 AANAT 16 AARS AARS AASS 18 ABAT 19 ABCA1

NCBI ID Symbol 2 A2M A4GALT A4GNT 8086 AAAS 13 AADAC AADACL AAGAB 15 AANAT 16 AARS AARS AASS 18 ABAT 19 ABCA1 NCBI ID Symbol 2 A2M 53947 A4GALT 51146 A4GNT 8086 AAAS 13 AADAC 344752 AADACL2 79719 AAGAB 15 AANAT 16 AARS 57505 AARS2 10157 AASS 18 ABAT 19 ABCA1 10349 ABCA10 26154 ABCA12 154664 ABCA13 20 ABCA2 21

Διαβάστε περισσότερα

Figure S1: Deletion of Dlx3 in the NC A) LacZ staining of Dlx3 LacZ/WT mice (a) and Wnt1- cre:r26r LacZ mice (b) at E11.5. The arrowhead points at

Figure S1: Deletion of Dlx3 in the NC A) LacZ staining of Dlx3 LacZ/WT mice (a) and Wnt1- cre:r26r LacZ mice (b) at E11.5. The arrowhead points at Figure S1: Deletion of Dlx3 in the NC A) LacZ staining of Dlx3 LacZ/WT mice (a) and Wnt1- cre:r26r LacZ mice (b) at E11.5. The arrowhead points at Dlx3 expression in the branchial arches. B) PCR and Southern

Διαβάστε περισσότερα

encouraged to use the Version of Record that, when published, will replace this version. The most /BCJ

encouraged to use the Version of Record that, when published, will replace this version. The most /BCJ Biochemical Journal: this is an Accepted Manuscript, not the final Version of Record. You are encouraged to use the Version of Record that, when published, will replace this version. The most up-to-date

Διαβάστε περισσότερα

Retinoic Acid Mediates Visceral-specific Adipogenic Defects of Human Adipose-derived Stem Cells

Retinoic Acid Mediates Visceral-specific Adipogenic Defects of Human Adipose-derived Stem Cells Retinoic Acid Mediates Visceral-specific Adipogenic Defects of Human Adipose-derived Stem Cells Kosuke Takeda, Sandhya Sriram, Xin Hui Derryn Chan, Wee Kiat Ong, Chia Rou Yeo, Betty Tan, Seung-Ah Lee,

Διαβάστε περισσότερα

Supplementary Information Supplementary Materials and Methods Multiple myeloma specimens Primary bone marrow samples from 116 MM patients and 12 patients without tumors were obtained from the 4th Department

Διαβάστε περισσότερα

Catalog No Name Size. A Trx-tag Antibody, pab, Goat 40 μg. A GST-tag Antibody [HRP], pab, Rabbit 40 μg

Catalog No Name Size. A Trx-tag Antibody, pab, Goat 40 μg. A GST-tag Antibody [HRP], pab, Rabbit 40 μg GenScript would like to best support your research needs. For any 40ug antibody product priced at $99/vial, we re offering you the following promotion program! *Terms and Conditions This promotion is valid

Διαβάστε περισσότερα

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Chang K, Taggart MW, Reyes-Uribe L, et al. Immune profiling of premalignant lesions in patients with Lynch syndrome. JAMA Oncol. Published online April 16, 2018. doi:10.1001/jamaoncol.2018.1482

Διαβάστε περισσότερα

Elevated free fatty acid uptake via CD36 promotes epithelial-mesenchymal transition in. and *Christina Chan

Elevated free fatty acid uptake via CD36 promotes epithelial-mesenchymal transition in. and *Christina Chan Elevated free fatty acid uptake via CD36 promotes epithelial-mesenchymal transition in hepatocellular carcinoma Aritro Nath 1, Irene Li 2, Lewis R. Roberts 3 1, 2, 4 and *Christina Chan 1 Genetics Program,

Διαβάστε περισσότερα

Santa Cruz Biotechnology, Inc.

Santa Cruz Biotechnology, Inc. sc-24 X sc-40 X sc-41 X sc-42 X sc-44 X sc-45 X sc-46 X sc-48 X sc-50 X sc-52 X sc-59 X sc-61 X sc-70 X sc-71 X sc-73 X sc-74 X sc-109 X sc-110 X sc-111 X sc-112 X sc-113 X sc-114 X sc-122 X sc-126 X sc-131

Διαβάστε περισσότερα

Table S1. Full list of high-stringency HIF-1 binding sites

Table S1. Full list of high-stringency HIF-1 binding sites Table S1. Full list of high-stringency HIF-1 HIF-1 ( Nearest gene locus 1 chr7 156986147 156987039 314 N DNAJB6 NM_058246 2 chr8 134456859 134457261 180 N NDRG1 NM_006096 3 chr1 114156539 114157002 288

Διαβάστε περισσότερα

Nature Immunology: doi: /ni.3575

Nature Immunology: doi: /ni.3575 Supplementary Figure 1 Histology of lymphoma and segregation of the mutation with the disease phenotype. (a) Histology of adenoid biopsy showing low grade B-cell lymphoma compatible with marginal zone

Διαβάστε περισσότερα

Supplemental Table S1. Tumor specific networks are enriched with somatically mutated genes (taken from the database COSMIC)

Supplemental Table S1. Tumor specific networks are enriched with somatically mutated genes (taken from the database COSMIC) Additional file 1 Supplemental Table S1. Tumor specific networks are enriched with somatically mutated genes (taken from the database COSMIC) COSMIC genes in tumor network COSMIC genes not in tumor network

Διαβάστε περισσότερα

ΠΑΝΕΠΙΣΤΗΜΙΟ ΘΕΣΣΑΛΙΑΣ ΣΧΟΛΗ ΕΠΙΣΤΗΜΩΝ ΥΓΕΙΑΣ ΤΜΗΜΑ ΙΑΤΡΙΚΗΣ

ΠΑΝΕΠΙΣΤΗΜΙΟ ΘΕΣΣΑΛΙΑΣ ΣΧΟΛΗ ΕΠΙΣΤΗΜΩΝ ΥΓΕΙΑΣ ΤΜΗΜΑ ΙΑΤΡΙΚΗΣ ΠΑΝΕΠΙΣΤΗΜΙΟ ΘΕΣΣΑΛΙΑΣ ΣΧΟΛΗ ΕΠΙΣΤΗΜΩΝ ΥΓΕΙΑΣ ΤΜΗΜΑ ΙΑΤΡΙΚΗΣ ΕΡΓΑΣΤΗΡΙΟ ΚΥΤΤΑΡΟΓΕΝΕΤΙΚΗΣ ΚΑΙ ΜΟΡΙΑΚΗΣ ΓΕΝΕΤΙΚΗΣ ΠΡΟΓΡΑΜΜΑ ΜΕΤΑΠΤΥΧΙΑΚΩΝ ΣΠΟΥΔΩΝ «ΓΕΝΕΤΙΚΗ ΤΟΥ ΑΝΘΡΩΠΟΥ» ΔΙΠΛΩΜΑΤΙΚΗ ΕΡΓΑΣΙΑ «Σύγκριση μελετών

Διαβάστε περισσότερα

Nature Immunology: doi: /ni Supplementary Figure 1. IL-6 reporter mice.

Nature Immunology: doi: /ni Supplementary Figure 1. IL-6 reporter mice. Supplementary Figure 1 IL-6 reporter mice. (a) Targeted Il6 locus. The reporter cassette including a floxed stop cassette was introduced into exon 2 of the Il6 locus. Since the locus is disrupted by this

Διαβάστε περισσότερα

NES: normalized enrichment score (analyzed using KEGG pathway gene sets in the GSEA software); FDR:

NES: normalized enrichment score (analyzed using KEGG pathway gene sets in the GSEA software); FDR: Supplementary table1. List of gene sets with simultaneously altered the enrichment upon SAP18 overexpression and knockdown. Gene sets enriched by SAP18 and reduced by shsap18 SAP18 against LacZ shsap18

Διαβάστε περισσότερα

Supplementary Appendix; Figures S1-S16.

Supplementary Appendix; Figures S1-S16. Supplementary Appendix; Figures S1-S16. Supplementary Appendix; Figure S1. FACS-Purified reporter + T cells reveal greater transcriptional resolution than bulk CD4 cells. CD4 T cells were purified and

Διαβάστε περισσότερα

Validità 31/01/2013 PROMO CODE

Validità 31/01/2013 PROMO CODE Validità 31/01/2013 PROMO CODE SCP-P100192 SC Cat # Protein Name Application Y71-30G 14-3-3α/β Protein Western Blot Y71-30N 14-3-3α/β Protein Western Blot Y75-30G 14-3-3ε Protein Western Blot Y75-30N 14-3-3ε

Διαβάστε περισσότερα

SUPPLEMENTARY MATERIALS AND METHODS: Generation of conditional Ada3 knockout targeting construct-to generate a conditional targeting construct, we

SUPPLEMENTARY MATERIALS AND METHODS: Generation of conditional Ada3 knockout targeting construct-to generate a conditional targeting construct, we SUPPLEMENTARY MATERIALS AND METHODS: Generation of conditional Ada3 knockout targeting construct-to generate a conditional targeting construct, we examined the genomic structure of the mouse Ada3 gene.

Διαβάστε περισσότερα

RARα2 expression confers myeloma stem cell features. Ye Yang, Jumei Shi, Giulia Tolomelli, Hongwei Xu, Jiliang Xia, He Wang, Wen Zhou, Yi Zhou,

RARα2 expression confers myeloma stem cell features. Ye Yang, Jumei Shi, Giulia Tolomelli, Hongwei Xu, Jiliang Xia, He Wang, Wen Zhou, Yi Zhou, RARα2 expression confers myeloma stem cell features Ye Yang, Jumei Shi, Giulia Tolomelli, Hongwei Xu, Jiliang Xia, He Wang, Wen Zhou, Yi Zhou, Satyabrata Das, Zhimin Gu, Dana Levasseur, Fenghuang Zhan,

Διαβάστε περισσότερα

ΖΕΡΔΑΛΗΣ ΣΩΤΗΡΙΟΣ ΤΟ ΟΥΤΙ ΣΤΗ ΒΕΡΟΙΑ (1922-ΣΗΜΕΡΑ) ΘΕΣΣΑΛΟΝΙΚΗ 2005 1

ΖΕΡΔΑΛΗΣ ΣΩΤΗΡΙΟΣ ΤΟ ΟΥΤΙ ΣΤΗ ΒΕΡΟΙΑ (1922-ΣΗΜΕΡΑ) ΘΕΣΣΑΛΟΝΙΚΗ 2005 1 (1922- ) 2005 1 2 .1.2 1.1.2-3 1.2.3-4 1.3.4-5 1.4.5-6 1.5.6-10.11 2.1 2.2 2.3 2.4.11-12.12-13.13.14 2.5 (CD).15-20.21.22 3 4 20.,,.,,.,.,,.,.. 1922., (= )., (25/10/2004), (16/5/2005), (26/1/2005) (7/2/2005),,,,.,..

Διαβάστε περισσότερα

Molecule Species Code Size1 售價 (NTD) Size2 售價 (NTD) Size3 售價 (NTD) Size4 售價 (NTD) Size5 售價 (NTD) acpp Staphylococcus aureus CSB-EP015636SKX 50μg

Molecule Species Code Size1 售價 (NTD) Size2 售價 (NTD) Size3 售價 (NTD) Size4 售價 (NTD) Size5 售價 (NTD) acpp Staphylococcus aureus CSB-EP015636SKX 50μg acpp Staphylococcus aureus CSB-EP015636SKX 50μg $10,220 200μg $29,100 500μg $48,750 1mg $77,770 ACRV1 Human CSB-EP001186HU 50μg $10,220 200μg $29,100 500μg $48,750 1mg $77,770 ACTB Mouse CSB-RP076754m

Διαβάστε περισσότερα

LAPTM4B is associated with poor prognosis in NSCLC and promotes the. NRF2-mediated stress response pathway in lung cancer cells

LAPTM4B is associated with poor prognosis in NSCLC and promotes the. NRF2-mediated stress response pathway in lung cancer cells LAPTM4B is associated with poor prognosis in NSCLC and promotes the NRF2-mediated stress response pathway in lung cancer cells Yuho Maki, Junya Fujimoto, Wenhua Lang, Li Xu, Carmen Behrens, Ignacio I.

Διαβάστε περισσότερα

SUPPLEMENTARY INFORMATION

SUPPLEMENTARY INFORMATION SUPPLEMENTARY INFORMATION Supplementary Materials and Methods Cell culture conditions My-La, SR-786, HuT 78 and HH were grown in RPMI 1640 medium (Sigma Chemical, St Louis, MO, USA) supplemented with 10%

Διαβάστε περισσότερα

Supplementary Material for. Disruption of Ttll5/Stamp gene in male mice causes sperm malformation and infertility

Supplementary Material for. Disruption of Ttll5/Stamp gene in male mice causes sperm malformation and infertility Supplementary Material for Supplementary Material for Lee et al., Page 1 Disruption of Ttll5/Stamp gene in male mice causes sperm malformation and infertility Geun-Shik Lee, Yuanzheng He, Edward J. Dougherty,

Διαβάστε περισσότερα

Supplementary Materials for

Supplementary Materials for www.sciencemag.org/content/350/6266/1383/suppl/dc1 Supplementary Materials for RNA polymerase II associated factor 1 regulates the release and phosphorylation of paused RNA polymerase II Ming Yu, Wenjing

Διαβάστε περισσότερα

Supplementary Table 1. Primer sequences used for RT-qPCR validation of the microarray data. Primer. direction. Forward

Supplementary Table 1. Primer sequences used for RT-qPCR validation of the microarray data. Primer. direction. Forward Supplementary Table 1. Primer sequences used for RT-qPCR validation of the microarray data Gene Glyceraldehyde 3-phosphate dehydrogenase (Gapdh) Cell death-inducing DFFAlike effector a (Cidea) Peroxisome

Διαβάστε περισσότερα

SUPPLEMENTARY INFORMATION

SUPPLEMENTARY INFORMATION doi:10.1038/nature10648 Supplementary Figure 1: Timing of CHIR99021 exposure determines induction of FOXA2/LMX1A midbrain floor plate precursors. a) Immunocytochemical analysis of FOXA2(red)/LMX1A(green)

Διαβάστε περισσότερα

Supplementary Fig. 1. Nature Medicine: doi: /nm z Donor # BB-z. 28- IL2RB-z (YXXQ) 28-IL2RBz (YXXQ) Control MFI: 1866 MFI:

Supplementary Fig. 1. Nature Medicine: doi: /nm z Donor # BB-z. 28- IL2RB-z (YXXQ) 28-IL2RBz (YXXQ) Control MFI: 1866 MFI: Supplementary Fig. 1 a Donor # 28-IL2RB-z 28- IL2RB-z Control MFI: 1866 1394 612 1297 11 MFI: 1794 1294 566 1225 11 MFI: 1433 1157 327 1117 98.5 MFI: 1463 1224 352 111 126 MFI: 1441 1232 497 1268 151 MFI:

Διαβάστε περισσότερα

Proteins for All February 15, 2016 May 15, 2016

Proteins for All February 15, 2016 May 15, 2016 PRESENTS In partnership with Cusabio, BioAspect is pleased to announce the new Proteins for All promotion that will run from February 15, 2016 until May 15, 2016. During this promotional period, the purchase

Διαβάστε περισσότερα

Supplemental Materials and Results

Supplemental Materials and Results Supplementary Figures and Legends Supplemental Materials and Results Supplementary Figure 1. Metabolic parameters in Ad-mKO mice A. TG content in skeletal muscle of Ctrl and Ad-mKO mice on chow diet (CD)

Διαβάστε περισσότερα

Supplementary Information

Supplementary Information Supplementary Information Recurrent PAX3-MAML3 Fusion in Biphenotypic Sinonasal Sarcoma Xiaoke Wang 1,, Krista L. Bledsoe 2,, Rondell P. Graham 1,, Yan W. Asmann 3, David S. Viswanatha 1, Jean E. Lewis

Διαβάστε περισσότερα

Zhang et al., Supplemental figures, Methods, References and Tables

Zhang et al., Supplemental figures, Methods, References and Tables 1 2 Zhang et al., Supplemental figures, Methods, References and Tables Supplemental figures 3 4 5 6 7 8 9 10 11 14 15 16 17 18 19 20 Supplemental Figure 1. Geminin interacts with FoxO3 (A and B) Cell lysates

Διαβάστε περισσότερα

Jmjd1c is Required for MLL-AF9 and HOXA9 Mediated AML Stem Cell Self- Renewal

Jmjd1c is Required for MLL-AF9 and HOXA9 Mediated AML Stem Cell Self- Renewal Supplemental Information Jmjd1c is Required for MLL-AF9 and HOXA9 Mediated AML Stem Cell Self- Renewal Nan Zhu, Mo Chen, Rowena Eng, Joshua DeJong, Amit U. Sinha, Noushin F. Rahnamay, Richard Koche, Fatima

Διαβάστε περισσότερα

Supplementary Information for. RRM2B Suppresses Activation of the Oxidative Stress Pathway and is. Up-regulated by P53 During Senescence

Supplementary Information for. RRM2B Suppresses Activation of the Oxidative Stress Pathway and is. Up-regulated by P53 During Senescence Supplementary Information for RRM2B Suppresses Activation of the Oxidative Stress Pathway and is Up-regulated by P53 During Senescence Mei-Ling Kuo 1,**, Alexander J. Sy 1, Lijun Xue 1, Martin Chi 1, Michelle

Διαβάστε περισσότερα

Supplementary Materials for

Supplementary Materials for www.sciencemag.org/cgi/content/full/science.aab3369/dc1 Supplementary Materials for Dengue subgenomic RNA binds TRIM25 to inhibit interferon expression for epidemiological fitness Gayathri Manokaran, Esteban

Διαβάστε περισσότερα

Nature Medicine doi: /nm.2457

Nature Medicine doi: /nm.2457 ature Medicine doi:10.1038/nm.2457 ature Medicine doi:10.1038/nm.2457 ature Medicine doi:10.1038/nm.2457 ature Medicine doi:10.1038/nm.2457 ature Medicine doi:10.1038/nm.2457 Table S1 - Candidate genes

Διαβάστε περισσότερα

Analysis Summary: Any Allergy

Analysis Summary: Any Allergy Analysis Summary: Any Allergy Phenotype Description The any_allergy phenotype includes cases identified from the union of the following sources: Allergies and Asthma survey: An allergic reaction (with

Διαβάστε περισσότερα

Supplementary Table S1. Primary antibodies for Western blot analysis. Antibody name and specifications

Supplementary Table S1. Primary antibodies for Western blot analysis. Antibody name and specifications Supplementary Table S1. Primary antibodies for Western blot analysis. Antibody name and specifications Manufacturer Actin (C-11) sc-1615, Santa Cruz, CA Akt1 (B-1) sc-5298 GAPDH (6C5) sc-32233 JAK2 (HR-758)

Διαβάστε περισσότερα

Supplementary Methods

Supplementary Methods Supplementary Methods Immunohistochemistry Five-micrometer-thick sections of formalin-fixed, paraffin-embedded tissue specimens were deparaffinized and dehydrated. All sections were incubated with anti-human

Διαβάστε περισσότερα

ΟΡΟΙ ΚΑΙ ΠΡΟΥΠΟΘΕΣΕΙΣ ΣΧΕΔΙΟΥ

ΟΡΟΙ ΚΑΙ ΠΡΟΥΠΟΘΕΣΕΙΣ ΣΧΕΔΙΟΥ ΟΡΟΙ ΚΑΙ ΠΡΟΥΠΟΘΕΣΕΙΣ ΣΧΕΔΙΟΥ 1. Η διαφήμιση της Τράπεζας για τα "Διπλά Προνόμια από την American Express" ισχύει για συναλλαγές που θα πραγματοποιηθούν από κατόχους καρτών Sunmiles American Express, American

Διαβάστε περισσότερα

Nature Immunology: doi: /ni Supplementary Figure 1. Foxm1 loss leads to bone marrow hypocellularity.

Nature Immunology: doi: /ni Supplementary Figure 1. Foxm1 loss leads to bone marrow hypocellularity. Supplementary Figure 1 Foxm1 loss leads to bone marrow hypocellularity. (a-b) Analysis of ablation of Foxm1 as determined by semiquantitative PCR analysis of genomic DNA (a) as well as qrt-pcr analysis

Διαβάστε περισσότερα

(A) Rounds of replating (R) of MLL-AF9 transformed LSK colonies from initiation

(A) Rounds of replating (R) of MLL-AF9 transformed LSK colonies from initiation upplemental Figure. (A) Rounds of replating (R) of LL-AF transformed LK colonies from initiation experiments (.E. of triplicate experiments, p=.)., p

Διαβάστε περισσότερα

Hazmat notification prior to departure from a Greek port

Hazmat notification prior to departure from a Greek port Hazmat notification prior to departure from a Greek port New notification//νέα αναφορά Notification update//ενημέρωση αναφοράς Αναφορά προ απόπλου πλοίου με επικίνδυνα ή ρυπογόνα από ελληνικό λιμένα Must

Διαβάστε περισσότερα

Unique peptides 1 DHX9 ATP-dependent RNA Q MYBBP1A Myb-binding protein 1A Q9BQG ADAR Adenosine deaminase, Q59EC

Unique peptides 1 DHX9 ATP-dependent RNA Q MYBBP1A Myb-binding protein 1A Q9BQG ADAR Adenosine deaminase, Q59EC SUPPLEMENTAL TABLES Supplemental Table 1: List of proteins identified by mass spectrometry. # Symbol Characteristics of proteins Accession number Molecular weight (kda) Unique peptides 1 DHX9 ATP-dependent

Διαβάστε περισσότερα

Hazmat notification prior to entry into a Greek port

Hazmat notification prior to entry into a Greek port Hazmat notification prior to entry into a Greek port New notification//νέα αναφορά Notification update//ενημέρωση αναφοράς Αναφορά προ κατάπλου πλοίου με επικίνδυνα ή ρυπογόνα σε ελληνικό λιμένα Must be

Διαβάστε περισσότερα

!! " &' ': " /.., c #$% & - & ' ()",..., * +,.. * ' + * - - * ()",...(.

!!  &' ':  /.., c #$% & - & ' (),..., * +,.. * ' + * - - * (),...(. ..,.. 00 !!.6 7 " 57 +: #$% & - & ' ()",..., * +,.. * ' + * - - * ()",.....(. 8.. &' ': " /..,... :, 00. c. " *+ ' * ' * +' * - * «/'» ' - &, $%' * *& 300.65 «, + *'». 3000400- -00 3-00.6, 006 3 4.!"#"$

Διαβάστε περισσότερα

Hazmat notification prior to entry into a Greek port

Hazmat notification prior to entry into a Greek port Hazmat notification prior to entry into a Greek port New notification//νέα αναφορά Notification update//ενημέρωση αναφοράς Αναφορά προ κατάπλου πλοίου με επικίνδυνα ή ρυπογόνα σε ελληνικό λιμένα Must be

Διαβάστε περισσότερα

Pax8 and Pax2 are specifically required at different steps of Xenopus pronephros development

Pax8 and Pax2 are specifically required at different steps of Xenopus pronephros development Pax8 and Pax2 are specifically required at different steps of Xenopus pronephros development Isabelle Buisson, Ronan Le Bouffant, Mélinée Futel, Jean-François Riou, Muriel Umbhauer To cite this version:

Διαβάστε περισσότερα

ΗΜΟΚΡΙΤΕΙΟ ΠΑΝΕΠΙΣΤΗΜΙΟ ΘΡΑΚΗΣ ΤΜΗΜΑ ΜΟΡΙΑΚΗΣ ΒΙΟΛΟΓΙΑΣ ΚΑΙ ΓΕΝΕΤΙΚΗΣ ΓΟΝΙ ΙΑΚΗ ΕΚΦΡΑΣΗ ΚΑΙ ΣΗΜΑΤΟ ΟΤΗΣΗ

ΗΜΟΚΡΙΤΕΙΟ ΠΑΝΕΠΙΣΤΗΜΙΟ ΘΡΑΚΗΣ ΤΜΗΜΑ ΜΟΡΙΑΚΗΣ ΒΙΟΛΟΓΙΑΣ ΚΑΙ ΓΕΝΕΤΙΚΗΣ ΓΟΝΙ ΙΑΚΗ ΕΚΦΡΑΣΗ ΚΑΙ ΣΗΜΑΤΟ ΟΤΗΣΗ ΗΜΟΚΡΙΤΕΙΟ ΠΑΝΕΠΙΣΤΗΜΙΟ ΘΡΑΚΗΣ ΤΜΗΜΑ ΜΟΡΙΑΚΗΣ ΒΙΟΛΟΓΙΑΣ ΚΑΙ ΓΕΝΕΤΙΚΗΣ ΓΟΝΙ ΙΑΚΗ ΕΚΦΡΑΣΗ ΚΑΙ ΣΗΜΑΤΟ ΟΤΗΣΗ ρ. Α. ΓΑΛΑΝΗΣ agalanis@mbg.duth.gr Figure 6.1 The Biology of Cancer ( Garland Science 2007) Figure

Διαβάστε περισσότερα

«ΧΑΡΑΚΤΗΡΙΣΜΟΣ ΜΕΤΑΓΡΑΦΙΚΩΝ ΜΟΝΟΠΑΤΙΩΝ ΕΠΙΘΗΛΙΟΥ ΠΟΥ ΣΥΝΔΕΟΝΤΑΙ ΜΕ ΤΗΝ ΑΛΛΕΡΓΙΑ (ΑΝΑΦΟΡΑ)»

«ΧΑΡΑΚΤΗΡΙΣΜΟΣ ΜΕΤΑΓΡΑΦΙΚΩΝ ΜΟΝΟΠΑΤΙΩΝ ΕΠΙΘΗΛΙΟΥ ΠΟΥ ΣΥΝΔΕΟΝΤΑΙ ΜΕ ΤΗΝ ΑΛΛΕΡΓΙΑ (ΑΝΑΦΟΡΑ)» ΠΑΡΑΔΟΤΕΟ: Π.3.4 «ΧΑΡΑΚΤΗΡΙΣΜΟΣ ΜΕΤΑΓΡΑΦΙΚΩΝ ΜΟΝΟΠΑΤΙΩΝ ΕΠΙΘΗΛΙΟΥ ΠΟΥ ΣΥΝΔΕΟΝΤΑΙ ΜΕ ΤΗΝ ΑΛΛΕΡΓΙΑ (ΑΝΑΦΟΡΑ)» ΓΙΑ ΤΟ ΥΠΟΕΡΓΟ 1 ΤΗΣ ΠΡΑΞΗΣ: «ΘΑΛΗΣ- Ίδρυμα Ιατροβιολογικών Ερευνών Ακαδημίας Αθηνών- Ωρίμανση

Διαβάστε περισσότερα

DrugBank. Vol. 39 Issue 13 July NECT BAI51B CXTD JYBZZ-XS-110. Tel

DrugBank. Vol. 39 Issue 13 July NECT BAI51B CXTD JYBZZ-XS-110. Tel * * 100102 - DrugBank - - - - 1 - - 5 2 3-4 - 2013-11-27 81373985 81173568 NECT-11-0605 2008BAI51B01 2011-6 CXTD-11 2013-JYBZZ-XS-110 * Tel 010 84738620 E-mail wangyun @ bucm. edu. cn * 010 84738620 E-mail

Διαβάστε περισσότερα

http / / cjbmb. bjmu. edu. cn Chinese Journal of Biochemistry and Molecular Biology RT-PCR Runx d PCR RT-qPCR Western BMPs Wnt Ihh

http / / cjbmb. bjmu. edu. cn Chinese Journal of Biochemistry and Molecular Biology RT-PCR Runx d PCR RT-qPCR Western BMPs Wnt Ihh ISSN 1007-7626 CN 11-3870 / Q http / / cjbmb bjmu edu cn Chinese Journal of Biochemistry and Molecular Biology 2011 6 27 6 540 ~ 547 micrornas * / / 250062 microrna mrna β- RT-PCR Runx2 0 7 14 d micrornas

Διαβάστε περισσότερα

和光纯药 细胞因子 生长因子 μg Activin A, Animal-derived-free

和光纯药 细胞因子 生长因子 μg Activin A, Animal-derived-free 和光纯药 细胞因子 生长因子 产品编号产品名称等级容量保存 / 法规 014-23961 10μg Activin A, Animal-derived-free 018-23964 500μg 011-23231 APRIL (expressed in insect cells)[tnfsf13] [TNFSF13] 10μg 014-19671 AITRL [TNFSF18] 20μg 016-23781

Διαβάστε περισσότερα

a 2,5 b 2,5 upplemental Figure 1 IL4 (4h) in Ja18-/- mice IFN-γ (16h) in Ja18-/- mice 1,5 1,5 ng/ml ng/ml 0,5 0,5 4ClPh PyrC 4ClPh PyrC

a 2,5 b 2,5 upplemental Figure 1 IL4 (4h) in Ja18-/- mice IFN-γ (16h) in Ja18-/- mice 1,5 1,5 ng/ml ng/ml 0,5 0,5 4ClPh PyrC 4ClPh PyrC a 2,5 IL4 (4h) in Ja18-/- mice b 2,5 IFN-γ (16h) in Ja18-/- mice 2 2 ng/ml 1,5 ng/ml 1,5 1 1,5,5 4ClPh NC PyrC 4ClPh NC PyrC upplemental Figure 1 a b c PyrC-α-GalCer NU-α-GalCer α-galcer CD4 (PE) MFI CD4

Διαβάστε περισσότερα

3.4 SUM AND DIFFERENCE FORMULAS. NOTE: cos(α+β) cos α + cos β cos(α-β) cos α -cos β

3.4 SUM AND DIFFERENCE FORMULAS. NOTE: cos(α+β) cos α + cos β cos(α-β) cos α -cos β 3.4 SUM AND DIFFERENCE FORMULAS Page Theorem cos(αβ cos α cos β -sin α cos(α-β cos α cos β sin α NOTE: cos(αβ cos α cos β cos(α-β cos α -cos β Proof of cos(α-β cos α cos β sin α Let s use a unit circle

Διαβάστε περισσότερα

SUPPLEMENTARY INFORMATION. Supplemenary Figures Figure S1

SUPPLEMENTARY INFORMATION. Supplemenary Figures Figure S1 doi: 10.1038/nature05939 SUPPLEMENTARY INFORMATION Supplemenary Figures Figure S1 wt MEF.1 wt MEF.2 wt MEF.Myc.1 wt MEF.Myc.2 wt MEF.Ras.1 wt MEF.Ras.2 wt MEF.E1A/Ras.1 wt MEF.E1A/Ras.2 p53-/- MEF.E1A/Ras.1

Διαβάστε περισσότερα

Supplementary Table S1 Demographic characteristics of HCC patients

Supplementary Table S1 Demographic characteristics of HCC patients Supplementary Table S1 Demographic characteristics of HCC patients Age (year; mean ± SD) 53.950 ± 11.802 Gender (number; %) Male 79 (79%) Female 21 (21%) AFP (ng/ml; mean ± SD) 23928.571 ± 79577.084 Tumor

Διαβάστε περισσότερα

SUPPORTING INFORMATION

SUPPORTING INFORMATION SUPPORTING INFORMATION Heronamides A C, new polyketide macrolactams from an Australian marine-derived Streptomyces sp. A biosynthetic case for synchronized tandem electrocyclization. Ritesh Raju, Andrew

Διαβάστε περισσότερα

RF series Ultra High Q & Low ESR capacitor series

RF series Ultra High Q & Low ESR capacitor series RF series Ultra High Q & Low ESR capacitor series FAITHFUL LINK Features Application» High Q and low ESR performance at high frequency» Telecommunication products & equipments:» Ultra low capacitance to

Διαβάστε περισσότερα

STARTING STEPS IN GRAMMAR, FINAL TEST C TERM 2012 UNITS 1-18

STARTING STEPS IN GRAMMAR, FINAL TEST C TERM 2012 UNITS 1-18 STARTING STEPS IN GRAMMAR, FINAL TEST C TERM 2012 UNITS 1-18 Name.. Class. Date. EXERCISE 1 Answer the question. Use: Yes, it is or No, it isn t. Απάντηςε ςτισ ερωτήςεισ. Βάλε: Yes, it is ή No, it isn

Διαβάστε περισσότερα

Supplementary Table 1: Primer sequence used in real-time PCR for binding site validation

Supplementary Table 1: Primer sequence used in real-time PCR for binding site validation Supplementary Table 1: Primer sequence used in real-time PCR for binding site validation Gene Region (hg19) Primer TCF7L2 chr10:114709983-114710213 TCGCCCTGTCAATAATCTCC AGCCGAAGATACAGGAGGTG TCF7L2 chr10:114767138-114767346

Διαβάστε περισσότερα

HepG hotmail. com. HepG2 Bid Bcl-2. HepG2 G0 /G1 Bid Bcl-2. HepG2. HepG2

HepG hotmail. com. HepG2 Bid Bcl-2. HepG2 G0 /G1 Bid Bcl-2. HepG2. HepG2 588 HepG2 2 2 53002 E-mail huan_chaos@ hotmail. com 2 3602 HepG2 MTT PI HepG2 Western Blot HepG2 Bid Bcl-2 HepG2 HepG2 G0 /G Bid Bcl-2 Bax Bid Bcl-2 Bax HepG2 HepG2 R 735. 7 A 0253-4304 204-588-05 DOI

Διαβάστε περισσότερα

(C) 2010 Pearson Education, Inc. All rights reserved.

(C) 2010 Pearson Education, Inc. All rights reserved. Connectionless transmission with datagrams. Connection-oriented transmission is like the telephone system You dial and are given a connection to the telephone of fthe person with whom you wish to communicate.

Διαβάστε περισσότερα

Legends for Supplemental Data

Legends for Supplemental Data Legends for Supplemental Data Supplemental Fig. 1. Top molecular and cellular functions identified by Ingenuity Pathway Analysis after 6 h (left) and 24 h (right) of exposure of mouse pancreatic islets

Διαβάστε περισσότερα

Growth Factors/Wachstumsfaktoren. Human (Hu) Cytokines and Growth Factors/Humane (Hu) Cytokine und Wachstumsfaktoren

Growth Factors/Wachstumsfaktoren. Human (Hu) Cytokines and Growth Factors/Humane (Hu) Cytokine und Wachstumsfaktoren Growth Factors/Wachstumsfaktoren Human (Hu) Cytokines and Growth Factors/Humane (Hu) Cytokine und Wachstumsfaktoren 4-1BBr Hu 4-1BB Receptor rec. CB-1010100 5 μg CB-1010101 20 μg CB-1010102 1 mg Acrp30

Διαβάστε περισσότερα

Growth Factors/Wachstumsfaktoren. Human (Hu) Cytokines and Growth Factors/Humane (Hu) Cytokine und Wachstumsfaktoren

Growth Factors/Wachstumsfaktoren. Human (Hu) Cytokines and Growth Factors/Humane (Hu) Cytokine und Wachstumsfaktoren 4-1BBr Hu 4-1BB Receptor rec. CB-1010100 5 μg CB-1010101 20 μg CB-1010102 1 mg Acrp30 Glob Hu Adiponectin Globular rec. CB-2800004 2 μg CB-2800005 10 μg CB-280000 1 mg Acrp30 HEK Hu Adiponectin glycosilated,

Διαβάστε περισσότερα

IL-7-dependent STAT1 activation limits homeostatic CD4 T cell expansion

IL-7-dependent STAT1 activation limits homeostatic CD4 T cell expansion Supplemental Material IL-7-dependent STAT1 activation limits homeostatic CD4 T cell expansion Cecile Le Saout 1, Megan A. Luckey 2, Alejandro V. Villarino 3, Mindy Smith 1, Rebecca B. Hasley 1, Timothy

Διαβάστε περισσότερα

Supplemental Table 1. Oligonucleotides used to identify H-RAS, K-RAS and N-RAS mutations and PTEN gene expression.

Supplemental Table 1. Oligonucleotides used to identify H-RAS, K-RAS and N-RAS mutations and PTEN gene expression. Supplemental Table 1. Oligonucleotides used to identify H-RAS, K-RAS and N-RAS mutations and PTEN gene expression. Gene Exon Forward primer Reverse primer Temp ( C) HRAS 2-3 ATGACGGAATATAAGCTGGT ATGGCAAACACACACAGGAA

Διαβάστε περισσότερα

1520 : : : [ ] ; ; ; [ ]R99 [ ]B [ ] (2015) DOI: /j.cnki.chinhosppharmacyj ResearchprogressoftoxicitymechanismofTr

1520 : : : [ ] ; ; ; [ ]R99 [ ]B [ ] (2015) DOI: /j.cnki.chinhosppharmacyj ResearchprogressoftoxicitymechanismofTr 1519 201210(27):34-35. [22]SerceOGursoyTOvaliFetal.EfectsofSaccharomyces boulardi on Neonatal Hyperbilirubinemia: A Randomized ControledTrial[J].AmJPerinatol201530(2):137-142. [23]. trialofeficacyandsafety[j].indianjpediatr201279(2):

Διαβάστε περισσότερα

OncoNext TM Risk-Oncoscreening

OncoNext TM Risk-Oncoscreening OncoNext TM Risk-Oncoscreening Το OncoNext TM Risk-Oncoscreening, επιτρέπει μία πολλαπλή γενετική ανάλυση που έχει στόχο την αξιολόγηση της προδιάθεσης για διάφορους τύπους κληρονομικών καρκίνων, όπως:

Διαβάστε περισσότερα

Thyristor & Diode Modules

Thyristor & Diode Modules Thyristor & We offer a broad range of PowerBLOCK modules containing thyristor and diode pellets in a voltage range of 1200V to 4400V and a current range of 61A up to 1070A. The modules are designed and

Διαβάστε περισσότερα

BD Cytometric Bead Array Flex Set System

BD Cytometric Bead Array Flex Set System BD Cytometric Bead Array Flex Set System BD Cytometric Bead Array System BD Biosciences Pharmingen ELISA Cytometric Bead Array CBA System Capture Caputure Serum Supernatant Lysate PE -Detection 1 2 PE

Διαβάστε περισσότερα

Supplementary Figure 1.

Supplementary Figure 1. Supplementary Figure 1. a 0.772% 0.0126% CD4 2.93% Lineage CD44 CD8 CD25 c-kit b WT Ly5.1 Bone marrow 1:1 Ltbr +/- or Ltbr -/- Ly5.2 10Gy WT % of CD45.2+ ETP among total ETPs 80 60 40 20 0 Ltbr +/- n.s.

Διαβάστε περισσότερα

Supplementary Table 1. Primers used for RT-qPCR analysis of striatal and nigral tissue.

Supplementary Table 1. Primers used for RT-qPCR analysis of striatal and nigral tissue. Supplementary Table 1. Primers used for RT-qPCR analysis of striatal and nigral tissue. Gene Forward Primer (5-3 ) Reverse Primer (5-3 ) Dopaminergic Markers TH CTG GCC ATT GAT GTA CTG GA ACA CAC ATG GGA

Διαβάστε περισσότερα

ΜΔΗΕΟΝ ΤΜΠΛΔΓΜΑ ΗΣΟΤΜΒΑΣΟΣΖΣΑ

ΜΔΗΕΟΝ ΤΜΠΛΔΓΜΑ ΗΣΟΤΜΒΑΣΟΣΖΣΑ ΜΔΗΕΟΝ ΤΜΠΛΔΓΜΑ ΗΣΟΤΜΒΑΣΟΣΖΣΑ 5 Σε όια ζρεδόλ ηα ζπνλδπισηά, ηα νπνία έρνπλ έσο ζήκεξα κειεηεζεί θαη ηδίσο ζηα ζειαζηηθά, ζπκπεξηιακβαλνκέλνπ θαη ηνπ αλζξώπνπ, έρεη δηαπηζησζεί ε ύπαξμε κηαο ζηελά ζπλδεδεκέλεο

Διαβάστε περισσότερα

Supplementary Materials for

Supplementary Materials for 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Supplementary Materials for PD-1 Marks Dysfunctional Regulatory T cells in Malignant Gliomas Daniel E. Lowther 1,, Brittany A. Goods 2,, Liliana E. Lucca 1,, Benjamin A.

Διαβάστε περισσότερα

Αίτηση για Εκχώρηση Άδειας Χρήσης Δικτυακού Ονόματος με κατάληξη.cy

Αίτηση για Εκχώρηση Άδειας Χρήσης Δικτυακού Ονόματος με κατάληξη.cy ΠΑΡΑΡΤΗΜΑ ΙΙΙ Για Επίσημη Χρήση A/A. Αίτηση για Εκχώρηση Άδειας Χρήσης Δικτυακού Ονόματος με κατάληξη.cy A1. Στοιχεία Καταχωρουμένου Όνομα Προσώπου: Αρ. Ταυτότητας: Διεύθυνση: Αρ. Τηλεφώνου: Αρ. Φαξ: Ηλεκτρονική

Διαβάστε περισσότερα

Nature Immunology: doi: /ni Supplementary Figure 1

Nature Immunology: doi: /ni Supplementary Figure 1 Supplementary Figure 1 T reg cell metabolism is regulated by Foxp3 and inflammatory signals. (a) CD4 + Foxp3 + T cells and CD4 + Foxp3 - T cells were analyzed by flow cytometry for Ki67 expression levels.

Διαβάστε περισσότερα

Supplemental Information. A p53 Super-tumor Suppressor Reveals a Tumor. Suppressive p53-ptpn14-yap Axis. in Pancreatic Cancer

Supplemental Information. A p53 Super-tumor Suppressor Reveals a Tumor. Suppressive p53-ptpn14-yap Axis. in Pancreatic Cancer Cancer Cell, Volume 32 Supplemental Information A p53 Super-tumor Suppressor Reveals a Tumor Suppressive p53-ptpn14-yap Axis in Pancreatic Cancer Stephano S. Mello, Liz J. Valente, Nitin Raj, Jose A. Seoane,

Διαβάστε περισσότερα

Το mir-29a ως βιοδείκτης στην υπερτροφική μυοκαρδιοπάθεια. Δ. Ντέλιος 1,2

Το mir-29a ως βιοδείκτης στην υπερτροφική μυοκαρδιοπάθεια. Δ. Ντέλιος 1,2 Το mir-29a ως βιοδείκτης στην υπερτροφική μυοκαρδιοπάθεια Δ. Ντέλιος 1,2 Υπερτροφική μυοκαρδιοπάθεια - 1:500 στο γενικό πληθυσμό Πρωτεΐνες του σαρκομεριδίου ΜΥΗ7, MYBPC3, TNNI3, TNNT2, TPM1, MYL3, MYL2

Διαβάστε περισσότερα

Ι Ε Θ Ν Ε Σ Ρ Ο Τ Α Ρ Υ Π Ε Ρ Ι Φ Ε Ρ Ε Ι Α 2 4 8 4

Ι Ε Θ Ν Ε Σ Ρ Ο Τ Α Ρ Υ Π Ε Ρ Ι Φ Ε Ρ Ε Ι Α 2 4 8 4 Ι Ε Θ Ν Ε Σ Ρ Ο Τ Α Ρ Υ Π Ε Ρ Ι Φ Ε Ρ Ε Ι Α 2 4 8 4 Ε Π Ι Σ Τ Ο Λ Η Δ Ι Ο Ι Κ Η Τ Η Α Υ Γ Ο Υ Σ Τ Ο Σ Μ η ν ι α ί α Ε π ι σ τ ο λ ή ι ο ι κ η τ ή 1 Π ε ρ ι ε χ ό μ ε ν α Σ ε λ ί δ ε ς Τ ο μ ή ν υ μ α τ

Διαβάστε περισσότερα

ΕΛΛΗΝΙΚΗ ΔΗΜΟΚΡΑΤΙΑ ΠΑΝΕΠΙΣΤΗΜΙΟ ΚΡΗΤΗΣ. Ψηφιακή Οικονομία. Διάλεξη 7η: Consumer Behavior Mαρίνα Μπιτσάκη Τμήμα Επιστήμης Υπολογιστών

ΕΛΛΗΝΙΚΗ ΔΗΜΟΚΡΑΤΙΑ ΠΑΝΕΠΙΣΤΗΜΙΟ ΚΡΗΤΗΣ. Ψηφιακή Οικονομία. Διάλεξη 7η: Consumer Behavior Mαρίνα Μπιτσάκη Τμήμα Επιστήμης Υπολογιστών ΕΛΛΗΝΙΚΗ ΔΗΜΟΚΡΑΤΙΑ ΠΑΝΕΠΙΣΤΗΜΙΟ ΚΡΗΤΗΣ Ψηφιακή Οικονομία Διάλεξη 7η: Consumer Behavior Mαρίνα Μπιτσάκη Τμήμα Επιστήμης Υπολογιστών Τέλος Ενότητας Χρηματοδότηση Το παρόν εκπαιδευτικό υλικό έχει αναπτυχθεί

Διαβάστε περισσότερα